Walgreens Boots Alliance meeting gives Deutsche Bank 'increased faith'

Investing.com

Published Nov 11, 2022 11:06AM ET

Updated Nov 11, 2022 11:29AM ET

Walgreens Boots Alliance (WBA) meeting gives Deutsche Bank 'increased faith'

By Sam Boughedda 

Walgreens Boots Alliance (NASDAQ:WBA) shares are up over 4% Friday after Deutsche Bank analysts upgraded the stock to Buy from Hold, raising the firm's price target on the stock to $50 from $41.

In a note to clients, the analysts explained that they recently hosted a meeting with senior management at Walgreens, where "investors' focus was squarely on the recently announced Summit/Village MD acquisition deal," as well as the company's shift to a healthcare services company.

Earlier this week, it was announced that Walgreens-backed VillageMD will acquire Summit Health in a deal valued at $9 billion.

"We came away from the meeting with increased faith in the company's ability to execute on its care delivery strategy, which should lead to positive revisions and multiple expansion for WBA shares," the analysts wrote.

He added that the Summit deal has generally been seen as a positive by investors, and a key theme in their meetings was Walgreens' transition from a pharmacy-led healthcare business to a more comprehensive consumer healthcare services company with pharmacy as a "key leg in the stool."

"The Summit deal catapults Walgreens through VillageMD into the position as one of the largest investor owned, multi-payer primary care business in the US (UNH at No. 1), expecting to exit 2023 with more than 700 locations and generating $8B in revenue. The Summit deal likely sidelines WBA from large scale M&A near term, as the company moves into integration mode for the next 12-18 months," the analysts concluded.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes